Spectroscopic markers of neurodegeneration in the mesial prefrontal cortex predict survival in ALS

References

• Abrahams S, Goldstein LH, Simmons A, Brammer M, Williams SC, Giampietro V, et al. Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study. Brain. 2004;127:1507–17.
   PubMed Web of Science ®Google Scholar
• Rippon GA, Scarmeas N, Gordon PH, Murphy PL, Albert SM, Mitsumoto H, et al. An observational study of cognitive impairment in amyotrophic lateral sclerosis. Arch Neurol. 2006;63:345–52.
   PubMed Web of Science ®Google Scholar
• Lepow L, Van Sweringen J, Strutt AM, Jawaid A, MacAdam C, Harati Y, et al. Frontal and temporal lobe involvement on verbal fluency measures in amyotrophic lateral sclerosis. J Clin Exp Neuropsychol. 2010;32:913–22.
   PubMed Web of Science ®Google Scholar
• Quinn C, Elman L, McCluskey L, Hoskins K, Karam C, Woo JH, et al. Frontal lobe abnormalities on MRS correlate with poor letter fluency in ALS. Neurology. 2012;79:583–8.
   PubMed Web of Science ®Google Scholar
• Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65:586–90.
   PubMed Web of Science ®Google Scholar
• Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83:102–8.
   PubMed Web of Science ®Google Scholar
• Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007;6:994–1003.
   PubMed Web of Science ®Google Scholar
• van Langenhove T, van der Zee J, van Broeckhoven C. The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum. Ann Med. 2012;44:817–28.
   PubMed Web of Science ®Google Scholar
• Grosskreutz J, Kaufmann J, Frädrich J, Dengler R, Heinze H-J, Peschel T, et al. Widespread sensorimotor and frontal cortical atrophy in amyotrophic lateral sclerosis. BMC Neurol. 2006;6:17.
   PubMed Web of Science ®Google Scholar
• Woolley SC, Zhang Y, Schuff N, Weiner MW, Katz JS. Neuroanatomical correlates of apathy in ALS using 4 Tesla diffusion tensor MRI. Amyotroph Lateral Scler. 2011;12:52–8.
   PubMed Web of Science ®Google Scholar
• Verstraete E, Veldink JH, Hendrikse J, Schelhaas HJ, van den Heuvel MP, van den Berg LH. Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2012;83:383–8.
   PubMed Web of Science ®Google Scholar
• Abe K, Takanashi M, Watanabe Y, Tanaka H, Fujita N, Hirabuki N, et al. Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis. Neuroradiology. 2001;43:537–41.
   PubMed Web of Science ®Google Scholar
• Usman U, Choi C, Camicioli R, Seres P, Lynch M, Sekhon R, et al. Mesial prefrontal cortex degeneration in amyotrophic lateral sclerosis: a high-field proton MR spectroscopy study. AJNR Am J Neuroradiol. 2011;32:1677–80.
   PubMed Web of Science ®Google Scholar
• Mandrioli J, Faglioni P, Nichelli P, Sola P. Amyotrophic lateral sclerosis: prognostic indicators of survival. Amyotroph Lateral Scler. 2006;7:211–20.
   PubMed Web of Science ®Google Scholar
• Westeneng HJ, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 2018;17:423–33.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Salachas F, Lacomblez L, Le Forestier N, Pradat PF, Bruneteau G, et al. Predicting survival of patients with amyotrophic lateral sclerosis at presentation: a 15-year experience. Neurodegener Dis. 2013;12:81–90.
   PubMed Web of Science ®Google Scholar
• Moura M, Novaes M, Eduardo E, Zago Y, Freitas R, Casulari L. Prognostic factors in amyotrophic lateral sclerosis: a population-based study. PLoS One. 2015;10:1–11.
   Web of Science ®Google Scholar
• Aridegbe T, Kandler R, Walters S, Walsh T, Shaw P, McDermott C. The natural history of motor neuron disease: assessing the impact of specialist care. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:13–9.
   PubMed Web of Science ®Google Scholar
• Skillback T, Mattsson N, Blennow K, Zetterberg H. Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:1–7.
   Web of Science ®Google Scholar
• Kalra S, Vitale A, Cashman NR, Genge A, Arnold DL. Cerebral degeneration predicts survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2006;77:1253–5.
   PubMed Web of Science ®Google Scholar
• Agosta F, Pagani E, Petrolini M, Sormani MP, Caputo D, Perini M, et al. MRI predictors of long-term evolution in amyotrophic lateral sclerosis. Eur J Neurosci. 2010;32:1490–6.
   PubMed Web of Science ®Google Scholar
• Bede P, Bokde AL, Byrne S, Elamin M, McLaughlin RL, Kenna K, et al. Multiparametric MRI study of ALS stratified for the C9orf72 genotype. Neurology. 2013;81:361–9.
   PubMed Web of Science ®Google Scholar
• Bowen BC, Pattany PM, Bradley WG, Murdoch JB, Rotta F, Younis AA, et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol. 2000;21:647–58.
   PubMed Web of Science ®Google Scholar
• Pohl C, Block W, Karitzky J, Traber F, Schmidt S, Grothe C, et al. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol. 2001;58:729–35.
   PubMedGoogle Scholar
• Suhy J, Miller RG, Rule R, Schuff N, Licht J, Dronsky V, et al. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Neurology. 2002;58:773–9.
   PubMed Web of Science ®Google Scholar
• Rule RR, Suhy J, Schuff N, Gelinas DF, Miller RG, Weiner MW. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:141–9.
   PubMed Web of Science ®Google Scholar
• Kalra S, Hanstock CC, Martin WR, Allen PS, Johnston WS. Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy. Arch Neurol. 2006;63:1144–8.
   PubMedGoogle Scholar
• Unrath A, Ludolph AC, Kassubek J. Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study. J Neurol. 2007;254:1099–106.
   PubMed Web of Science ®Google Scholar
• Choi C, Ogilvie CJ, Malykhin N, Ngo JTV, Hartfeil MAW, Coupland NJ. Detection of the myo-inositol 4.06-ppm resonance by selective J rewinding: application to human prefrontal cortex in vivo. Magn Reson Med. 2005;54:1536–40.
   PubMed Web of Science ®Google Scholar
• Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, et al. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2008;79:33–7.
   PubMed Web of Science ®Google Scholar
• Czaplinski A, Yen AA, Appel SH. Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol. 2006;253:1428–36.
   PubMed Web of Science ®Google Scholar
• Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310–23.
   PubMed Web of Science ®Google Scholar
• Kalra S. Magnetic resonance spectroscopy in ALS. Front Neurol. 2019;10:482.
   PubMed Web of Science ®Google Scholar
• Schuster C, Hardiman O, Bede P. Survival prediction in amyotrophic lateral sclerosis based on MRI measures and clinical characteristics. BMC Neurol. 2017;17:73.
   PubMed Web of Science ®Google Scholar
• Ishaque A, Mah D, Seres P, Luk C, Eurich D, Johnston W, et al. Evaluating the cerebral correlates of survival in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2018;5:1350–61.
   PubMed Web of Science ®Google Scholar
• Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013;74:20–38.
   PubMed Web of Science ®Google Scholar
• Braak H, Del Tredici K. Anterior cingulate cortex TDP-43 pathology in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2018;77:74–83.
   PubMed Web of Science ®Google Scholar
• Irwin DJ, McMillan CT, Brettschneider J, Libon DJ, Powers J, Rascovsky K, et al. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013;84:163–9.
   PubMed Web of Science ®Google Scholar
• Hu WT, Shelnutt M, Wilson A, Yarab N, Kelly C, Grossman M, et al. Behavior matters – cognitive predictors of survival in amyotrophic lateral sclerosis. PLoS One. 2013;8:e57584.
   PubMed Web of Science ®Google Scholar
• Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol. 2012;11:232–40.
   PubMed Web of Science ®Google Scholar
• Srivastava O, Hanstock C, Chenji S, Mah D, Eurich D, Ta D, et al. Cerebral degeneration in ALS: a prospective multicentre MRS study. Neurol Clin Pract. 2019;9:400–7.
   PubMedGoogle Scholar